9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Incyte Corporation
Esperas Pharma Inc.
Cyteir Therapeutics, Inc.
Eli Lilly and Company
Syros Pharmaceuticals
Bayer
Gilead Sciences
Celgene
Western Regional Medical Center
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Northwestern University
Altor BioScience
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)